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Abstract
Genetic nomenclature for Caenorhabditis species and other nematodes is supervised by WormBase in
collaboration with the Caenorhabditis Genetics Center (CGC) and with essential input from the community of
scientists working on C. elegans and other nematodes.

1. Introduction
Genetic nomenclature allows the genetic features of an organism to be structured and described in a uniform
and systematic way. Genetic features, including genes, variations (both natural and induced), and gene products, are
assigned descriptors that inform on the nature of the feature. These nomenclature designations facilitate
communication among researchers (in publications, presentations, and databases) to advance understanding of the
biology of the genetic feature and the experimental utilization of organisms that contain the genetic feature.
The nomenclature system that is used for C. elegans was first employed by Sydney Brenner (1974) in his
landmark description of the genetics of this model organism, and then substantially extended and modified in
Horvitz et al., 1979. The gene, allele, and chromosome rearrangement nomenclature, described below, is an
amalgamation of that from bacteria and yeast, with the rearrangement types from Drosophila. The nomenclature
avoids standard words, subscripts, superscripts, and Greek letters and includes a hyphen (-) to separate the gene
name from gene number (distinct genes with similar phenotypes or molecular properties). As described by Jonathan
Hodgkin, ‘the hyphen is about 1 mm in length in printed text and therefore symbolizes the 1 mm long worm’. These
nomenclature properties make C. elegans publications highly suitable for informatic text mining, as there is minimal
ambiguity. From the founding of the Caenorhabditis Genetics Center (CGC) in 1979 until 1992, Don Riddle and
Mark Edgley acted as the central repository for genetic nomenclature. Jonathan Hodgkin was nomenclature czar
from 1992 through 2013; this was a pivotal period with the elucidation of the genome sequence of C. elegans, and
later that of related nematodes, and the inception of WormBase. Thus, under the guidance of Hodgkin, the
nomenclature system became a central feature of WormBase and the number and types of genetic features
significantly expanded. The nomenclature system remains dynamic, with recent additions including guidelines
related to genome engineering, and continued reliance on the community for input.
WormBase assigns specific identifying codes to each laboratory engaged in dedicated long-term genetic
research on C. elegans. Each laboratory is assigned a laboratory/strain code for naming strains, and an allele code
for naming genetic variation (e.g., mutations) and transgenes. These designations are assigned to the laboratory
head/PI who is charged with supervising their organization in laboratory databases and their associated biological
reagents that are described on WormBase, in publications, and distributed to the scientific community on request.
The laboratory/strain code is used: a) to identify the originator of community-supplied information on WormBase,
which, in addition to attribution, facilitates communication between the community/curators and the originator if an
issue related to the information should arise at a later date; and b) to provide a tracking code for activities at the
CGC. The laboratory/strain designation consists of 2-3 uppercase letters while the allele designation has 1-3
lowercase letters. The final letter of a laboratory code should not be an “O” or an “I” so as not to be mistaken for the
numbers “0” or “1” respectively. Additionally, allele designations should also not end with the letter “l” which could
also be mistaken for the number “1.” These codes are listed at the CGC and in WormBase. Investigators generating
strains, alleles, transgenes, and/or defining genes require these designations and should apply for them at
genenames@wormbase.org.
Information for several other nematode species, in addition to C. elegans, is curated at WormBase. All species
are referred to by their Linnean binomial names (e.g,. Caenorhabditis elegans or C. elegans). Details of all the
genomes available at WormBase and the degree of their curation can be found at www.wormbase.org/species/all

2. Genes
Three different gene naming schemes are employed in WormBase: GeneIDs, Sequence Names, and Gene
Names.
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First, for all genes WormBase has assigned a unique accession of the form ‘WBGene#’, for example
‘WBGene00000024’. The accession uniquely refers to a locus at a specific location in the genome: either a protein
coding sequence (CDS) and transcript structure, an uncloned gene, a non-coding RNA transcript, a defined sequence
element, or pseudogene. This accession follows the gene through any changes that may be made to it based on
bioinformatics predictions or experimentation. If the gene object is split into two genes, the original accession will
usually apply to the 5’ gene and a new accession will be assigned to the other half.
Second, for nearly all C. elegans genes WormBase has assigned a Sequence Name, which is derived from the
cosmid, fosmid, or YAC clone on which they reside, and which was used to generate the reference Bristol N2
genome sequence (The C. elegans Sequencing Consortium, 1998). For example ‘AC3.3’, indicates that the gene is
on cosmid AC3, and that there are at least 2 other genes (.1 and .2) on that cosmid.
Finally, for a number of loci, a standard genetic gene name is employed, which usually refers to mutant
phenotype or some aspect of sequence similarity. Researchers who are investigating such genes are encouraged to
propose gene names based on the guidelines in Section 2.1 and Section 2.2. Genetic gene names consist of a three or
four letter gene class name, e.g., “abu” (for Activated in Blocked Unfolded protein response), followed by a hyphen
and a number: “abu-1”. A small number of gene objects defined by mutation are currently uncloned, and until
associated with a sequence name will appear with just a standard genetic name. Publications commonly use the
genetic name, as this designation provides information about function in biological processes, potential molecular
function based on sequence similarity, or in some cases known biochemical activity. Sequence names for genes
lacking a genetic name, of which there are many, are also used in publications, often with -omic level studies where
functional information may be limited.
2.1. Applying for new gene class and/or gene names
Investigators wishing to propose new gene names for C. elegans should note the summary guidelines below
and apply online via WormBase or by email application to genenames@wormbase.org. It is highly recommended
that investigators contact WormBase with their gene name proposal prior to submission of a manuscript or abstract,
as proposed gene names are not always used as the main name on WormBase. Reasons for not using a proposed
name as the main name include the gene already having a name (usually being held in confidence; see Section
2.2.8.) or that the name is inappropriate based on incorrect sequence analysis or other type of ambiguity.
2.2. Guidelines for proposing new gene names
2.2.1.

Gene names must conform to the standard format of 3 or 4 letters gene class name, hyphen, number.
2.2.2.

Genes can be named on the basis of a mutant phenotype or on the basis of the predicted protein product or
RNA product.
2.2.3.

For genes defined by mutation, the approved gene names refer to the mutant phenotype originally detected or
most easily scored e.g., dumpy (dumpy) in the case of dpy-5, lethal (lethal) in the case of let-37.
2.2.4.

For genes defined on the basis of sequence similarity or sequence features, the approved gene name refers to
the predicted protein product, RNA product, or gene causing a disease, e.g., myosin light chain in the case of mlc-3,
superoxide dismutase in the case of sod-1, or nephronophthisis (human kidney disease) homolog, in the case of
nphp-4.
2.2.5.

Gene names based on homology with a previously named gene in another well-studied organism (e.g., Homo
sapiens) or that is the standard in the relevant field (e.g., DNA replication) are often appropriate and desirable,
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especially where there is convincing orthology between genes (e.g., wrn-1 is the C. elegans ortholog of the human
gene WRN1, responsible for Werner's syndrome, or rnt-1 is the C. elegans ortholog of the Drosophila gene runt).
2.2.6.

If a new gene clearly belongs in an existing gene class, then a new gene number will be assigned after
consultation with the laboratory responsible for the gene class in question.
2.2.7.

If the establishment of a new gene class name seems more appropriate, then approval for this gene name must
be obtained, preferably online via WormBase or by email application to genenames@wormbase.org. To avoid the
situation of multiple names for the same gene in the literature, approval should be sought prior to abstract or
manuscript submission.
2.2.8.

New gene name classes can be assigned in confidence, prior to formal publication or disclosure in an abstract.
2.2.9.

Gene names that are memorable, informative, and simply explained are encouraged.
2.2.10.

Gene names and gene numbering schemes that conform to established nomenclature proposals for particular
protein classes are desirable.
2.2.11.

Gene names including c (for Caenorhabditis), ce (for C. elegans), n (for nematode) or w (for worm) are
discouraged. C. elegans as the organism of origin can be specified with a prefix (Cel-) if desired, e.g., Cel-fem-1.
2.2.12.

Gene names based solely on RNAi phenotypes or high-throughput analysis of gene expression or protein
interactions are discouraged.
2.2.13.

A limited number of genes have been given temporary tag- names (tag = temporarily assigned gene name).
These are genes for which deletion alleles have been generated by reverse genetic methods, but which have not yet
been given more informative names based on sequence or mutant phenotype. When sufficient information becomes
available, each tag name will be replaced by an appropriate standard 3- or 4-letter name.
2.2.14.

If a gene produces a protein that can be classified as a member of a family, the gene may also be assigned an
approved name consisting of three or four italicized letters, a hyphen, and an italicized Arabic number, e.g., nhr-49,
indicating that this is the 49th member of the nhr (nuclear hormone receptor) gene family.
2.2.15.

There are a few exceptions to this format. Genes in a paralogous set related to a single named gene are
sometimes given the same gene name and number, followed by a distinguishing decimal. For example, four C.
elegans genes homologous to SIR2 in S. cerevisiae have been given the names sir-2.1, sir-2.2, sir-2.3, sir-2.4.
2.2.16.

A limited number of genes, named on the basis of sequence homology, have been given non-standard names
ending with alphanumeric identifiers rather than with simple numbers in order to make these names closer to the
4
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generally accepted names used in other organisms. For example, eif-3.B, eif-3.C, eif-3.D, etc. encode proteins of the
conserved translation factor eIF3.
2.2.17.

The gene name may, on rare occasions, be followed by an italicized Roman numeral to indicate the
chromosome (linkage group) on which the gene resides, e.g., dpy-5 I (chromosome I) or let-37 X or mlc-3 III.
2.2.18.

Genes with related properties are often given the same 3 or 4 letter gene class name and different numbers. For
example, there are three known myosin light chain genes: mlc-1, mlc-2, mlc-3, and more than twenty different
dumpy genes: dpy-1, dpy-2, dpy-3, and so on.
2.2.19.

There is no specific nomenclature for pseudogenes. The Overview section on the WormBase gene page
indicates if the gene is designated as a pseudogene.
2.3. Approved gene name conflicts
Approved gene names that have been established in databases and have been used in a body of published
literature should preferably not be changed. In cases where a gene has received multiple names, one name will be
adopted as the main name for the gene on WormBase. The other names will continue to be listed in WormBase,
where relevant associations can be found through search features. Whenever possible, name changes or the adoption
of a single main name should be made with the approval of all laboratories concerned.

3. Guidelines for variation data
Variation is defined as a change in genome sequence compared to the reference C. elegans Bristol N2
sequence. Variation can be experimentally induced (e.g., chemical mutagenesis, genome engineering) or found in C.
elegans strains isolated from natural environments. The term allele is applied both to experimentally-induced change
and natural variation whether the change produces a phenotype or not. The term mutation is often applied to
experimentally-induced variation which can often result in phenotypic deviation. The term polymorphism is applied
to natural variation, and often does not result in a phenotype. The Bristol N2 reference strain is defined by
convention as wild type. However, during laboratory propagation Bristol N2 can accumulate variation resulting in
differences from the reference Bristol N2 sequence. Therefore in cases where an investigator wants to associate
phenotype with genotype, multiple lines of evidence are necessary to draw the conclusion that variation x leads to
phenotype y. Every variation is assigned an accession of the form WBVariationDDDD. Some variations, for
example mutant alleles and polymorphisms of certain types, are assigned an additional allele name.
(Natural variation is discussed below in Section 5. Polymorphisms and other genetic elements.)
3.1. Alleles/mutations from experimentally induced variation
3.1.1.

Every allele has a unique designation. Alleles are given names consisting of one to three italicized letters (the
allele designation for the assigning laboratory) followed by an italicized Arabic number, e.g., e61 or mn138 or st5.
The last letter should not be an “l” to avoid confusion with the number “1”. For example, e refers (originally) to the
MRC Laboratory of Molecular Biology (Cambridge, U.K.), (currently) to the laboratory of J. Hodgkin (University
of Oxford), and st refers to the laboratory of R.H. Waterston (originally at Washington University, St. Louis, MO,
currently at the University of Washington, Seattle).
3.1.2.

When gene and allele names are used together, the allele name is included in parentheses after the gene name,
e.g., dpy-5(e61), let-37(mn138). When unambiguous (e.g., if only one allele is known for a given gene or if all work
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on a gene described in a publication used a single allele cited in a Methods section), gene names can be used in
preference to allele names (let-37 rather than mn138 or let-37(mn138)).
3.1.3.

Optional suffixes indicating characteristics of an allele can follow the allele name. These are usually two-letter
non-italicized letters, e.g., hc17ts, where ts stands for temperature-sensitive, or pk15te, where te stands for
transposon-excision.
3.1.4.

The wild type allele (version) of a gene is defined as that present in the Bristol N2 reference strain, stored
frozen at the CGC and other locations. The wild type allele can be designated by a plus sign immediately after the
gene name, dpy-5+, or, more commonly, by including the plus sign in parentheses, dpy-5(+).
3.2. Gene knockouts
3.2.1.

Many gene knockouts constructed to date are small deletions (<5 kb) generated by chemical mutagenesis, by
transposon excision, or by genome engineering. These are named as alleles, sometimes with the optional suffix te
(transposon-excision) or ko (knockout). Example: zyx-1(gk190) is a 777 bp deletion in the zyx-1 gene.
3.2.2.

Some of the small deletions generated by chemical mutagenesis, by transposon excision, or by genome
engineering may remove parts of two adjacent genes. If only two genes appear to be affected, then the deletion is
given a single allele name, but the genotype is written with both gene names coupled with an ampersand (&).
Example: allele ok615 is a 1422 bp deletion of two adjacent genes, so it can be written rad-54&tag-157(ok615).
3.2.3.

Deletions that affect more than two genes are named as Deficiencies “(Df)”, as described in Section 3.5
Chronmosomal aberrations.
3.3. Genome engineering
Genome engineering (CRISPR-Cas9, TALENs, etc.) is increasingly being applied to C. elegans and related
nematodes. The resulting genomic alterations require some additional recommendations. The aim is to provide
compact and unambiguous ways of describing and referring to engineered changes to endogenous loci, as distinct
from transgenic constructs that are inserted elsewhere in the genome.
3.3.1.

Each engineered modification to an endogenous locus (point mutations, deletions, insertions, or combinations
thereof) should receive a unique allele designation, using the standard allele designation of the originating
laboratory. For example: bus-50(e5000). A single allele designation is employed even if multiple changes are made
to the locus.
3.3.2.

Optional brackets can be employed to provide additional information. Example: bus-50(e5000[T110E]) (an
engineered missense mutation).
3.3.3.

A new allele designation is assigned for each independent, yet identical, engineered gene change. For
example, if in a structure/function analysis of gene-x, the co-conversion strategy used resulted in the R71C change in
dpy-10 in 15 strains containing modifications to gene-x, then 15 different allele designations need to be assigned to
dpy-10 (in additional to relevant allele assignments for gene-x).
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3.3.4.

An engineered fusion of GFP to the C-terminus of BUS-50 would be: bus-50(e5001[bus-50::gfp]). Similarly,
an N-terminal fusion would be: bus-50(e5100[gfp:bus-50]). In the case of an engineered internal GFP fusion, the
designation is the same as a C-terminal fusion, with a detailed description of the structure in the relevant publication.
3.3.5.

As a shorter and more convenient form, and where unambiguous, this could be referred to as: bus-50::gfp.
Such abbreviations should be clearly defined where first used in a publication.
3.3.6.

An engineered insertion of GFP plus the unc-119(+) selectable marker, flanked by loxP sites, would be:
bus-50(e5002[bus-50::gfp + loxP unc-119(+) loxP]).
3.3.7.

Each additional engineering of the endogenous locus requires a new allele number. In the example of
bus-50(e5002), following Cre-mediated recombinase removal of unc-119(+) so that a single loxP site remains, the
new genotype would be bus-50(e5003[bus-50::gfp +loxP]) or bus-50(e5003) for short. The original allele can be
indicated in brackets with a preceding asterisk (*), in order to allow searches for all derivatives from a given change.
The above example would be bus-50(e5003[*e5002]).
3.3.8.

Engineered insertions in apparent intergenic regions are given standard Is or Si (see Section 7.5) insertion
names, for example eIs2002. Optional descriptors can include the nature of the insertion, e.g., [unc-119::gfp] and
the position in the genome, e.g., [III:2992500], to give eIs2002[unc-119::gfp] or eIs2002[unc-119::gfp,
III:2992500].
3.3.9.

Engineered changes to existing integrated transgenes, either Is or Si, should receive new Is or Si numbers
using originating lab's prefix. The original Is or Si insertion can be indicated in brackets with a preceding asterisk
(*), in order to allow searches for all derivatives from a given insertion. For example, an engineered change from
GFP to mCherry in eIs2002 might be named as ozIs909, or ozIs909[unc-119::mCherry *eIs2002].
3.4. Modifiers: suppressors, revertants, and enhancers
3.4.1.

There is no special nomenclature for modifier mutations. Many extragenic suppressor loci are called sup (40
sup loci defined so far, with a wide variety of properties and mechanisms). An increasing number of more specific
modifier gene classes have been established, such as smu (suppressor of mec and unc), and smg (suppressor with
morphogenetic effect on genitalia) and sel (suppressor/enhancer of lin-12).
3.4.2.

Intragenic suppressors or modifiers are indicated by adding a second allele name within parentheses; for
example, unc-17(e245e2608) is an intragenic partial revertant of unc-17(e245).
3.4.3.

Mutations known to be chromosomal rearrangements, rather than intragenic lesions, are named differently, as
described in the Section 3.5.
3.5. Chromosomal aberrations.
Duplications (Dp), deficiencies (Df), inversions (In), and translocations (T) are known in C. elegans genetics
and cytogenetics. These are given italicized names consisting of the laboratory mutation prefix, the relevant
7
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abbreviation, and a number, optionally followed by the affected linkage groups in parentheses (e.g., eT1(III;V),
mnDp5(X;f), where f indicates a free duplication). If linkage groups are indicated in a translocation they should be in
the order ‘transposed from’; transposed to’. Chromosomal balancers of unknown structure can be designated using
the abbreviation C, e.g., mnC1(II). See WormBook chapter Genetic balancers for a more detailed explanation.

4. Polymorphisms and other genetic elements
4.1. SNPs and RFLPs
Polymorphic sites, which are mostly SNPs (single nucleotide polymorphisms) or RFLPs (restriction fragment
length polymorphisms) derived from natural isolates of C. elegans (and thus differ from the Bristol N2 reference)
are designated by an italic letter P and an italic number, preceded by the allele designation for the laboratory
responsible for identifying the site. For example, stP17 and stP196 are RFLPs identified in the laboratory of R.H.
Waterston, and amP6 and amP15 are SNPs identified in the laboratory of K. Kornfeld.
SNPs identified in whole genome sequencing projects from one or more natural isolates are not assigned a
name but may be referred to by their WBVariationID. For example, WBVar01710822 is an intronic SNP in the
npr-1 gene found in various natural isolates. Other identifiers (such as those used in publications, internal IDs
assigned by the project or historical names) are incorporated into WormBase to enable users to recover such entities
through searches.
4.2. Natural copy number variants
Hundreds of independent natural isolates of C. elegans have been recovered from multiple locations around
the world. The genomes of some of these isolates contain large (>10 kb) deletions, duplications, or insertions,
relative to the reference wild-type strain, Bristol N2. Deletions are named with the prefix niDf (natural isolate
deficiency) followed by a number. Duplications and insertions are named with the prefix niDp (natural isolate
duplication or insertion), followed by a number. Numbers for niDf and niDp variants are assigned by application to:
genenames@wormbase.org
4.3. Introgressed regions in near-isogenic lines.
Genetic regions that have been introgressed from one natural isolate of C. elegans into the background of a
different isolate are named in a manner similar to that used for deficiencies (Df) and duplications (Dp). Each
Introgressed Region is given an italicized name consisting of the relevant laboratory allele designation, the letters IR,
and a number. Thus, a region from the X chromosome of Hawaiian strain CB4856 crossed onto a Bristol N2
background, and created in the Kruglyak lab (allele code qq) has been given the name qqIR1. Additional information
about genetic map location and strain origin can be provided in an optional parenthesis. So this example could be
more fully written as qqIR1(X, CB4856), with the implicit assumption that the strain background is Bristol N2. The
strain background and the direction of introgression can also be specified, using the symbol >, with this example
being written qqR1(X, CB4856>N2).
4.4. Transposons and transposon insertions
Types of C. elegans transposons are called Tc1, Tc2, etc., where each number represents a different family.
Transposon names are not italicized except when included in a genotype. Different natural isolates of C. elegans
have different distributions of these transposons, which result in polymorphic differences from the reference
wild-type strain Bristol N2. The differences between natural isolates and Bristol N2 are given polymorphism names,
as described below.
The endogenous transposons of C. elegans can be mobilized to generate new insertional events. In addition,
foreign transposons such as Mos1 can be introduced by transformation, and then mobilized to create new insertions.
All these newly generated transposon insertions can be named as simple alleles, with an optional suffix indicating
the nature of the transposon. They are treated as alleles of named genes if they are located within the boundaries of a
gene. Example: r293 is a Tc1 insertion in the gene unc-54. An optional descriptor can also be added after a double
colon to indicate the nature of the insertion. Example: unc-54(r293::Tc1). Note that such insertions may often be
silent in terms of gene activity, for example if an insertion occurs within an intron and can be spliced out.
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Newly generated Transposon insertions, especially those located in apparently intergenic regions, may also be
given Ti (transposon insertion) names. These consist of the designation identifying the laboratory of origin, the two
letters Ti, and a number, all italicized. Example: eTi13 is an insertion of a Mos transposon into an intergenic region
on LGIII.
Transposon loci have ID names formed from ‘WBTransposon’ followed by a unique number, like
WBTransposon00000623.
Their exon-like structure is curated as a Transposon_CDS (coding sequence) object with a name like C29E6.6
formed from the YAC or cosmid or clone they are on followed by a number which uniquely identifies it from the
other CDS-like objects on that clone, YAC or cosmid.
Transposons and Transposon_CDS are not currently classed as genes in WormBase and so do not have a
parent gene object. The WBTransposon and representation on the Genome Browser should be viewed as analogous
to the WBGene and how it is displayed.
4.5. Transgenes
Transformation of C. elegans with exogenous DNA by microinjection usually leads to the formation of a
transmissible extrachromosomal array containing many copies of the introduced DNA. Extrachromosomal arrays
differ in their frequency of meiotic and mitotic transmission. Extrachromosomal arrays can subsequently be
integrated into the genome by irradiation. Direct integrative transformation with exogenous DNA can be obtained by
microparticle bombardment, mosSCI, or miniMos techniques. As these integrative events are not associated with the
endogenous locus corresponding to the exogenous DNA they are considered distinct from genome engineered
changes to the endogenous locus and thus have different designations.
4.5.1.

Extrachromosomal arrays are given italicized names consisting of the laboratory allele prefix, the two letters
Ex, and a number.
4.5.2.

Integrated transgenes are designated by italicized names consisting of the laboratory allele prefix, the two
letters Is, and a number. Single copy integrants, usually generated by the MosSCI or miniMos insertion techniques,
are a subset of integrated transgenes and are designated by italicized names consisting of the laboratory allele prefix,
the two letters Si, and a number.
4.5.3.

Transgene designations Ex, Is, and Si can optionally be followed by genotypic or molecular information
describing the transgene in square brackets. For example, eEx3 or eIs2 or stEx5[sup-7(st5) unc-22(+)].
4.5.4.

Gene fusions incorporated in transgenes that consist of a C. elegans gene or part thereof fused to a reporter
such as lacZ or GFP are indicated by the C. elegans gene name followed by two colons and the reporter, all
italicized: pes-1::lacZ, mab-9::GFP. To distinguish between transcriptional and translational fusions, a lowercase
italicized p following the gene name has been used to indicate transcriptional fusions, e.g., mab-9p::GFP.

5. Genotypes
The genotype of an animal is specified by listing all known differences between its genotype and that of wild
type, which is defined by convention as Bristol N2. Each such difference is assigned a unique name. Table 1 lists the
currently recognized types of difference that have designations, described at greater length elsewhere in the chapter.
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Table 1. Nomenclature terms and usage in C. elegans research
R107.8

Systematic gene identification (the 8th predicted gene on
cosmid R107)

lin

Gene class, “abnormal cell LINeage”

lin-12

The 12th “abnormal cell LINeage” gene named

ar170

Allele name (“ar” allele designation from the Greenwald
lab; the 170th allele generated in the Greenwald lab)

LIN-12

Protein name (product of lin-12 gene)

Lin

Phenotype (abnormal cell lineage phenotype)

lin-12(ar170) or lin-12(ar170)/lin-12(ar170)

Homozygous for lin-12(ar170) allele

lin-12(ar170)/+

Heterozygous for lin-12(ar170) allele

lin-12(ar170)/lin-12(n941)

Heterozygous for two different lin-12 alleles (also call a
compound heterozygote) (“n” allele designation from the
Horvitz lab)

lin-12(n676n930)

n930 is an intragenic revertant of the n676 lin-12 gain of
function allele

gk181351

Allele of lin-12 from the Million mutant project, MMP
(“gk” MMP allele numbering starts at 100000)

WBVar00070143

Single Nucleotide Polymorphism (SNP) in the lin-12
3’UTR found in the natural isolate CB4856 (Hawaiian
strain)

stP17

Restriction Fragment Length Polymorphism (RFLP)
(“st” allele designation from the Waterston lab)

lin-12p::gfp

GFP transcriptional fusion (using only the promoter of
the gene)

lin-12::gfp

GFP translational fusion (in which gfp is inserted at the
C-terminus of the lin-12 coding sequence)

GS60

Strain name (“GS” laboratory/strain designation from the
Greenwald lab); full genotype unc-32(e189)
lin-12(n676n930) III.

lin-41(tn1490)

lin-41 allele generated by chemical mutagenesis (“tn”
allele designation from the Greenstein lab)

lin-41(xe11)

lin-41 allele generated by genome engineering (“xe”
allele designation from the Grosshans lab)

lin-41(tn1490[G883E])

Amino acid change in lin-41 allele tn1490 indicated

mnDp26

Duplication (Dp) (“mn” allele designation from the
Herman lab)

nDf17

Deficiency (Df) (multi-gene deletion)

nT1 (IV; V)

Translocation (T) involving chromosomes IV and V

rtEx726

Extrachromosomal (Ex) transgene array (“rt” allele
designation from the Hart lab)

arIs80

Integrated (Is) transgene

dotSi110

Single copy insertion (Si) (“dot” allele designation from
the J. Chen lab)

glc-1(pk54::Tc1)

Transposon (Tc1) insertion in glc-1 gene (“pk” allele
designation from the Plasterk lab)
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pgIR2

Introgressed region (IR); full genotype (II, CB4856>N2),
which indicates that a region from chromosome II of the
Hawaiian strain CB4856 has been crossed into the
Bristol N2 background (“pg” allele designation from the
M. Goodman lab).

Where necessary, wild type sequence can be indicated using the symbol +. Because every genetic “feature”
(i.e., difference from Bristol N2) has a unique name, an animal's genotype is fully specified by listing all the named
features that it carries. Example: e2123; mdIs18.
For clarity and convenience, additional information about genes, chromosomes, transgene contents, etc., can
be added as described elsewhere in this document, to produce a more informative genotype. Example:
pha-1(e2123ts) III; mdIs18[pha-1(+) unc-17::GFP]
Strains carrying more than one mutation are designated by sequentially listing mutant genes or alleles
according to the left-right (= up-down) order on the genetic map/genome sequence. Different chromosomes (linkage
groups) are separated by a semicolon and given in the order I, II, III, IV, V, X, f, M. I-V are the five autosomes, X is
the X chromosome, f refers to free duplications or chromosomal fragments, and M is the mitochondrial genome. For
example: dpy-5(e61) I; bli-2(e768) II; unc-32(e189) III.
Integrated transgenes (Is and Si) should be grouped with other mutant genes or alleles on the chromosome, if it
is known into which chromosome the transgene is integrated. Extrachromosomal arrays (Ex) and unmapped
integrated arrays should be included at the end of the genotype. Example: oxTi330 III; gaIs283.
Heterozygotes, with allelic differences between chromosomes are designated by separating mutations on the
two homologous chromosomes with a slash. For example, the compound heterozygote lin-12(n941)/lin-12(n137).
Where unambiguous, wild type alleles can be designated by a plus sign alone, or even omitted. For example,
dpy-5(e61) unc-13(+)/dpy-5(+) unc-13(e51) I can also be written dpy-5 +/+ unc-13 or dpy-5/unc-13.

6. Phenotypes
Phenotypic characteristics can be described in words, e.g., dumpy animals or uncoordinated animals. If more
convenient, a nonitalicized 3-letter or 4-letter abbreviation, which usually corresponds to a gene class or gene name,
may be used. The first letter of a phenotypic abbreviation is capitalized, e.g., Unc for uncoordinated, Dpy for
dumpy. If it is necessary to distinguish among related but distinguishable phenotypes, the relevant gene number can
be added, e.g., Unc-4 and Unc-13 to differentiate the distinct phenotypes produced by mutations in the two genes
unc-4 and unc-13. WormBase maintains a standard set of defined phenotype descriptors (the WormBase Phenotype
Ontology).
Abbreviations that do not correspond to a gene class or gene name can also be used, e.g., Muv for multiple
vulval development, and Daf-c for dauer-formation-constitutive. To avoid ambiguity and conflicts, phenotype
abbreviations not corresponding to a gene name are controlled by WormBase and requests for names should be
made, prior to abstract or manuscript submission, via email to: genenames@wormbase.org.
A common and accepted convention, when comparing a mutant with the wild type, is to use the prefix non- to
refer to the wild type phenotype, for example, non-Lin (= wild type cell lineage) or Dpy non-Unc (= wild type with
respect to movement, but dumpy with respect to body shape).

7. Proteins
The protein product of a gene can be referred to by the relevant gene name, written in non-italic capitals, e.g.,
the protein encoded by unc-13 can be called UNC-13.
In some cases the gene name and the protein products have distinct names, often in situations where the gene
name is based on phenotype and the protein product is named based on sequence similarity or biochemical activity.
For example, for the gene let-60 and the corresponding protein RAS, designation let-60/RAS or let-60 RAS can be
used.
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Where more than one protein product is predicted for a gene (usually as a result of alternative message
processing), the different proteins are distinguished by adding ‘isoform’ and then the isoform letter derived from the
isoform letter of the name of the WormBase CDS, e.g., the gene ‘tra-1’ has two CDS isoforms: ‘Y47D3A.6a’ and
‘Y47D3A.6b’ which give rise to the protein isoforms: ‘TRA-1, isoform a’ and ‘TRA-1, isoform b’.
Mutant protein products can be named by the missense change, for example a mutant ‘TRA-1, isoform a’
protein with a Pro to Leu change at codon 79 would be written: ‘TRA-1, isoform a (P79L)’.

8. Strains
A strain is a set of individuals of a particular genotype with the capacity to produce more individuals of the
same genotype. Strains are given non-italicized names consisting of two or three uppercase letters followed by a
number. The strain letter prefixes refer to the laboratory of origin and are distinct from the allele (mutation) letter
prefixes. Examples: CB1833 is a strain of genotype dpy-5(e61) unc-13(e51), originally constructed by S. Brenner at
the MRC Laboratory of Molecular Biology (strain designation CB, allele designation e), and MT688 is a strain of
genotype unc-32(e189) +/+ lin-12(n137) III; him-5(e1467) V, constructed in the laboratory of H.R. Horvitz at
M.I.T. (strain designation MT, allele designation n).
Strains can and should be preserved as frozen stocks at −70 °C, or ideally in liquid nitrogen, in order to ensure
long-term maintenance and to avoid drift or accumulation of modifier mutations.
Bacterial strain names employ the two or three letter Laboratory/Strain designation, followed by “b”. For
example, CBb#. This facilitates distinguishing nematode strains from bacterial strains. Please provide full
information on species and relevant genotype of the bacteria.

9. Other nematodes
Research and genomic analysis of non-C. elegans species is increasing rapidly. An important mission of
WormBase is to make available information for each species listed in the Overview section within the database
structure developed for C. elegans. For these organisms WormBase will also supervise gene naming in order to
maximize consistency with C. elegans. It is recommended that nomenclature in general should follow the principles
used for C. elegans, as far as possible. Gene name proposals and queries should be made online via WormBase or
sent to genenames@wormbase.org
9.1. Species prefixes
In order to specify unambiguously the nematode species-of-origin, an optional 3-letter standard prefix and
hyphen can be added to the gene name (Table 2). Examples: the C. briggsae and Pristionchus pacificus orthologs of
C. elegans tra-1 are called Cbr-tra-1 and Ppa-tra-1, respectively. WormBase coordinates the species prefix
designations to avoid the use of the same designation for more than one species; contact genenames@wormbase.org
for prefix proposals.
Table 2. Species prefixes currently in use
Species

Prefix

C. elegans

Cel-

C. briggsae

Cbr-

C. remanei

Cre-

C. brenneri

Cbn-

C. japonica

Cpj-

Heterorhabditis bacteriophora

Hba-

Oscheius tipulae

Oti-

Pristionchus pacificus

Ppa-

For additional prefixes since publication of this article see WormBase
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9.2. Gene naming: homologous genes
Genes predicted from whole genome sequences in other nematode species will, in many cases, have
identifiable close homologs in C. elegans, for which approved names already exist. In these cases, the same name
should be used as in C. elegans, with the relevant species identifier. Possible scenarios are listed below.
9.2.1. One-to-one

Where one gene in C. elegans corresponds to a single gene in another nematode species, ortholog naming can
be applied automatically. Example: thoc-1 in C. elegans has a C. briggsae ortholog, Cbr-thoc-1.
9.2.2. One-to-many

Where one gene in C. elegans is related to multiple genes (paralogs) in another nematode species, these
paralogs can be named using additional decimal numbers. Example: thoc-3 in C. elegans has two C. briggsae
paralogs, Cbr-thoc-3.1 and Cbr-thoc-3.2.
9.2.3. Many-to-one

Where multiple genes exist in C. elegans but only a single gene in another nematode species, it is
recommended that either the most closely similar, or the lowest numbered C. elegans gene, be used to name the
single gene, as appropriate.
9.2.4. Many-to-many.

Where multiple closely related genes can be identified in both species but the phylogenetic relationships of the
two sets are complex, new gene numbers can be assigned to the set of genes in the other nematode species, after
consultation with genenames@wormbase.org
9.2.5. A standard gene name has not yet been assigned in C. elegans

The gene can be referred to using the sequence name, such as Hba-W01B11.3. However, in such cases it will
usually be both feasible and desirable to assign a standard name to the C. elegans gene as well, at the same time.
9.3. Gene naming: non-homologous genes
It is expected that many genes in other nematode species will lack obvious close homologs in C. elegans,
because of loss or substantial divergence during the evolution of C. elegans. These genes can be given new gene
numbers if they belong to an identifiable named class in C. elegans, or else new gene name classes can be
established for them. In either case, assignment of an approved name should be made after consultation with
genenames@wormbase.org
9.4. Gene naming: forward genetics
A significant amount of mutation-based forward genetic analysis is being pursued in nematodes other than C.
elegans, in particular using other species of Caenorhabditis (C. briggsae, C. remanei, C. brenneri, and others), as
well as species of Oscheius and Pristionchus. It is expected that most, but not all, of the mutationally-defined genes
discovered in these species will prove to have orthologs with equivalent or similar function in C. elegans, and hence
that standard genetic names will have been approved already. Possible situations are described below.
9.4.1. The molecular identity is known and orthology is obvious

It is recommended that the C. elegans name be used, with the appropriate species identifier prefix. Example:
Ppa-mab-5 is the Pristionchus pacificus ortholog of C. elegans mab-5.
9.4.2. The molecular identity is not initially known but the mutant phenotype corresponds to a known C.
elegans mutant phenotype

To reduce gene renaming as much as possible, it is recommended that: a) new mutations should be mapped as
precisely as possible, b) all relevant complementation tests should be done, and c) if the genome assembly for that
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species is sufficiently accurate, potential C. elegans orthologs should be tested by sequencing or RNAi. If the gene
still seems to be novel, then a new gene class name can be established, following consultation with
genenames@wormbase.org in order to ensure that the new name is available and appropriate. An appropriate name
should describe the phenotype yet be distinct from the corresponding C. elegans name. If the molecularly identity is
subsequently found to be conserved in C. elegans, then the name would typically revert to the C. elegans name, but
this would be determined on a case-by-case basis.
9.4.3. The molecular identity is unknown and the mutant phenotype does not correspond to a known C.
elegans mutant phenotype

A new gene class name can be established, following consultation with genenames@wormbase.org in order to
ensure that the new name is available and appropriate. Example: cov = Competence and/or centering Of Vulva
abnormal.

10. Acknowledgements
This work is funded by U41 HG002223D to WormBase (M.A.T and T.S.) and NIH-ORIP (P40 OD010440) to
the CGC (A.D.). The following individuals made substantial contributions to the C. elegans nomenclature system
and its utilization: Sydney Brenner, Robert Horvitz, Jonathan Hodgkin, Robert Herman, Phil Anderson, Mark
Edgley and Don Riddle.

11. References
Brenner S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94. Abstract Article
Harris T.W., Baran, J., Bieri, T., Cabunoc, A., Chan, J., Chen, W.J., Davis, P., Done, J., Grove, C., Howe, K., et al.
(2014). WormBase 2014: new views of curated biology. Nucleic Acids Res. 42 (Database Issue) D789-793. Abstract
Article
Horvitz H.R., Brenner, S., Hodgkin, J., and Herman, R.K. (1979). A uniform genetic nomenclature for the nematode
Caenorhabditis elegans. Mol. Gen. Genet. 175, 129-133. Abstract Article
The C. elegans Sequencing Consortium. (1998). Genome sequence of the nematode C. elegans: a platform for
investigating biology. Science 282, 2012-2018. Abstract Article

All WormBook content, except where otherwise noted, is licensed under a Creative
Commons Attribution License.
14

